Levoflox (Levofloxacin 500mg) is frequently chosen as a first-line treatment for community-acquired pneumonia because it offers an unusually broad spectrum of activity that covers nearly all the common pneumonia-causing pathogens in a single medication — including Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella species.
This broad "atypical pathogen" coverage is particularly valuable because, in many pneumonia cases, doctors cannot immediately identify which specific bacteria is causing the infection. Levoflox's ability to treat both typical bacterial pneumonia and atypical pneumonia caused by organisms like Mycoplasma means treatment can start immediately and effectively, without waiting for lab culture results.
Additionally, Levoflox has near-complete oral bioavailability of around 99%, meaning the oral tablet form works almost as effectively as an IV infusion. This allows hospitals to start patients on IV Levofloxacin if severely ill, then switch seamlessly to oral tablets as they improve — shortening hospital stays and reducing treatment costs significantly.
Levoflox is also convenient because it only needs to be taken once daily, improving patient compliance compared to antibiotics requiring multiple daily doses. Treatment duration for community-acquired pneumonia is typically 5-7 days, though more severe cases may require longer courses determined by the treating physician.
Unnati Pharmax supplies Levoflox to hospitals and pharmacies. Visit medshopy.com or WhatsApp +91 82650 41513 for institutional or retail orders.
This broad "atypical pathogen" coverage is particularly valuable because, in many pneumonia cases, doctors cannot immediately identify which specific bacteria is causing the infection. Levoflox's ability to treat both typical bacterial pneumonia and atypical pneumonia caused by organisms like Mycoplasma means treatment can start immediately and effectively, without waiting for lab culture results.
Additionally, Levoflox has near-complete oral bioavailability of around 99%, meaning the oral tablet form works almost as effectively as an IV infusion. This allows hospitals to start patients on IV Levofloxacin if severely ill, then switch seamlessly to oral tablets as they improve — shortening hospital stays and reducing treatment costs significantly.
Levoflox is also convenient because it only needs to be taken once daily, improving patient compliance compared to antibiotics requiring multiple daily doses. Treatment duration for community-acquired pneumonia is typically 5-7 days, though more severe cases may require longer courses determined by the treating physician.
Unnati Pharmax supplies Levoflox to hospitals and pharmacies. Visit medshopy.com or WhatsApp +91 82650 41513 for institutional or retail orders.
